- Home
- CNSP
as 11-15-2024 4:00pm EST
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 5.4M | IPO Year: | 2019 |
| Target Price: | $0.50 | AVG Volume (30 days): | 41.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.10 - $137.50 | Next Earning Date: | 11-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest CNS Pharmaceuticals Inc. News
CNSP Breaking Stock News: Dive into CNSP Ticker-Specific Updates for Smart Investing
ACCESSWIRE
3 days ago
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
ACCESSWIRE
14 days ago
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
MT Newswires
17 days ago
CNS Pharmaceuticals Receives More Time to Regain Compliance With Nasdaq Listing Requirement
ACCESSWIRE
17 days ago
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
ACCESSWIRE
a month ago
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
ACCESSWIRE
a month ago
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
ACCESSWIRE
a month ago
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
ACCESSWIRE
2 months ago
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
Compare CNSP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNSP CNS Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.